What amount sold does Equinext, LLC report in Form D filings?

The latest linked filings report $985K sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Equinext, LLC's most recent SEC filing?

Equinext, LLC's most recent Form D filing was on 2013-12-04.

How many investors does Equinext, LLC have?

The most recent Form D filing lists 11 investor(s).

What type of securities does Equinext, LLC offer?

Equinext, LLC's SEC Form D filings indicate equity offerings.

Equinext, LLC

CIK: 0001536165·Biotechnology·LEXINGTON, KY·Limited Liability Company·Founded 2011

Reported Sold

$985,003

Total Filings

Identified Offerings

Last Filed

Dec 4, 2013

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Dec 4, 2013Form D — New notice

Reported sold: $300,000 · Target: $500,000

Rule 506(b)·11 investors

Dec 1, 2011Form D — New notice

Reported sold: $685,003 · Target: $850,000

Rule 506·8 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$985,003

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Eric Hauck

Related Person

Appears on 2 filings

Thomas Hedman

Related Person

Appears on 2 filings

Kim Sprayberry

Related Person

Appears on 2 filings

Andrew Clark

Related Person

Appears on 2 filings

Jim Newberry

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Dec 4, 2013	New	$500,000	$300,000	11
Dec 1, 2011	New	$850,000	$685,003	8

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Opus KSD, Inc.

Biotechnology

Offering target: $680,801

Filed Oct 1, 2026